{"SPADE_UN_22510": {"Sequence Information": {"Peptide Name": "PYL-ME", "Sequence": "KIAKVALAKLGIGAVLKVLTTGL", "Sequence Length": 23, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "Q99134", "uniprotUrl": "http://www.uniprot.org/uniprot/Q99134", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}, {"uniprotId": "P01501", "uniprotUrl": "http://www.uniprot.org/uniprot/P01501", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Short bioactive peptides", "Pubmed ID": "", "Reference": "PATENT US 6875744B2. 2005;:", "Author": "Owen DR, Kenner LA", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"}], "Mass": 2277.87, "PI": 10.48, "Net Charge": 4, "Hydrophobicity": 1.29, "Frequent Amino Acids": "LAK", "Absent Amino Acids": "CDEFHMNOPQRSUWY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 14, "Polar Residues": 9, "Positive Residues": 4, "Negative Residues": 0, "SPADE ID": "SPADE_UN_22510", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_22510", "Similarity": 1.0, "Sequence": "KIAKVALAKLGIGAVLKVLTTGL"}, {"SPADE_ID": "SPADE_N_02602", "Similarity": 1.0, "Sequence": "GIGAVLKVLTTGLPALISWIKRKRQQ"}, {"SPADE_ID": "SPADE_N_04203", "Similarity": 1.0, "Sequence": "GIGAVLKVLTTGLPALISWISRKKRQQ"}], "Hemolytic Activity": "Human fibroblasts WI-38:LD50=430 µg/ml", "Target Organism": "Staphylococcus aureus ATCC 6538(MIC=200µg/ml),Pseudomonas aeruginosa ATCC 9027(MIC=200µg/ml),Saccharomyces cerevisiae(MFC=>200µg/ml),Escherichia coli ATCC 25922(MBC=25µg/ml),Pseudomonas aeruginosa ATCC 27853(MBC=>50µg/ml),Candida albicans ATCC 10231(MFC=>50µg/ml),Human breast adenocarcinoma MCF-7(LD50=635µg/ml),Human colon adenocarcinoma SW480(LD50=>1000µg/ml),Human lung carcinoma H1299(LD50=>1000µg/ml),Human cervical carcinoma HeLa S3(LD50=>1000µg/ml)"}}}